HEMATOLOGIC NEOPLASM

Clinical trials for HEMATOLOGIC NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new HEMATOLOGIC NEOPLASM trials appear

Sign up with your email to follow new studies for HEMATOLOGIC NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Blood cancer drug safety checked in small Follow-Up study

Knowledge-focused Completed

This study looked at the long-term safety of an oral drug called azacitidine in people with blood cancers. Only 5 people who had already taken the drug in earlier studies took part. The main goal was to track any side effects that happened during the extended treatment.

Matched conditions: HEMATOLOGIC NEOPLASM

Phase: PHASE2 • Sponsor: Celgene • Aim: Knowledge-focused

Last updated May 01, 2026 15:58 UTC

HEMATOLOGIC NEOPLASM

Get alerted when new HEMATOLOGIC NEOPLASM trials appear

Blood cancer drug safety checked in small Follow-Up study